Robert Hershberg Insider Trades & Stock Holdings

Director · Recursion Pharmaceuticals, Inc. · Latest filing Oct 6, 2026

Robert Hershberg, Director at Recursion Pharmaceuticals, Inc. has 1 Form 4 trade on file since Oct 6, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($125K), net -$125K. Latest filing: disposed of 25K shares of $RXRX on Oct 6, 2026 at $5.

Trades on file

1

Open-market bought

$0

Open-market sold

$125K

Net open-market

-$125K

Latest filing

Oct 6, 2026

All insider trades by Robert Hershberg

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 6, 2026	$RXRX	Sell (Open-market sale) 10b5-1	25K	$5	$125K			-17.3%			Director		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Robert Hershberg traded

• $RXRX

Frequently asked questions

Has Robert Hershberg been buying or selling stock?

Robert Hershberg has 0 open-market purchases and 1 open-market sale on file, net -$125K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Robert Hershberg's latest insider trade?

disposed of 25K shares of $RXRX on Oct 6, 2026 at $5.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.